
Isaac Shomer
Examiner (ID: 12146, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1343 |
| Issued Applications | 756 |
| Pending Applications | 157 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15083273
[patent_doc_number] => 20190336447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/511380
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511380 | Liposome composition and method for producing same | Jul 14, 2019 | Issued |
Array
(
[id] => 16009057
[patent_doc_number] => 20200179371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => Stabilizing Camptothecin Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 16/510394
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510394 | Stabilizing Camptothecin Pharmaceutical Compositions | Jul 11, 2019 | Abandoned |
Array
(
[id] => 15990179
[patent_doc_number] => 20200170960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED NANOPARTICLES FOR THERAPY OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/505668
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505668
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505668 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED NANOPARTICLES FOR THERAPY OF PROSTATE CANCER | Jul 7, 2019 | Abandoned |
Array
(
[id] => 15321213
[patent_doc_number] => 20200000936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => BLOCK COPOLYMERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/459039
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/459039 | BLOCK COPOLYMERS AND USES THEREOF | Jun 30, 2019 | Abandoned |
Array
(
[id] => 16776587
[patent_doc_number] => 20210113664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 17/253078
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253078 | IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES | Jun 24, 2019 | Pending |
Array
(
[id] => 15205927
[patent_doc_number] => 20190365650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => TARGETED POLYMERIZED NANOPARTICLES FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/444842
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/444842 | Targeted polymerized nanoparticles for cancer treatment | Jun 17, 2019 | Issued |
Array
(
[id] => 15264909
[patent_doc_number] => 20190381188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same
[patent_app_type] => utility
[patent_app_number] => 16/438762
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438762 | Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same | Jun 11, 2019 | Abandoned |
Array
(
[id] => 18116294
[patent_doc_number] => 11547666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Cationic lipids comprising a steroidal moiety
[patent_app_type] => utility
[patent_app_number] => 17/058334
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36506
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058334 | Cationic lipids comprising a steroidal moiety | May 29, 2019 | Issued |
Array
(
[id] => 16961641
[patent_doc_number] => 20210213140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => Phosphoester Cationic Lipids
[patent_app_type] => utility
[patent_app_number] => 17/058557
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058557 | Phosphoester Cationic Lipids | May 28, 2019 | Abandoned |
Array
(
[id] => 15083235
[patent_doc_number] => 20190336428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => Prebiotic Oral Care Methods Using a Saccharide
[patent_app_type] => utility
[patent_app_number] => 16/424927
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424927 | Prebiotic oral care methods using a saccharide | May 28, 2019 | Issued |
Array
(
[id] => 16138823
[patent_doc_number] => 10702465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Oral care formulation and method for the removal of tartar and plaque from teeth
[patent_app_type] => utility
[patent_app_number] => 16/422340
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 17728
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422340 | Oral care formulation and method for the removal of tartar and plaque from teeth | May 23, 2019 | Issued |
Array
(
[id] => 19120090
[patent_doc_number] => 11964051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Ribose cationic lipids
[patent_app_type] => utility
[patent_app_number] => 17/054886
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 45362
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054886 | Ribose cationic lipids | May 14, 2019 | Issued |
Array
(
[id] => 14774739
[patent_doc_number] => 20190262267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => PHARMACEUTICAL SOLUTION HAVING A TOXICITY-REDUCING EFFECT FOR ANTITUMOR DRUGS, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 16/407736
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16407736
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/407736 | Pharmaceutical solution having a toxicity-reducing effect for antitumor drugs, and pharmaceutical composition comprising same | May 8, 2019 | Issued |
Array
(
[id] => 14712481
[patent_doc_number] => 20190247304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => TREATING INFLAMMATION WITH INHALED ASPIRIN
[patent_app_type] => utility
[patent_app_number] => 16/396272
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396272 | Treating inflammation with inhaled aspirin | Apr 25, 2019 | Issued |
Array
(
[id] => 16822547
[patent_doc_number] => 20210137840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => LIPID-BASED FORMULATIONS FOR THE DELIVERY OF RNA
[patent_app_type] => utility
[patent_app_number] => 17/050441
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050441 | LIPID-BASED FORMULATIONS FOR THE DELIVERY OF RNA | Apr 24, 2019 | Abandoned |
Array
(
[id] => 16822554
[patent_doc_number] => 20210137847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide
[patent_app_type] => utility
[patent_app_number] => 17/052947
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052947 | Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide | Apr 23, 2019 | Issued |
Array
(
[id] => 15239367
[patent_doc_number] => 20190374469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => APTAMER BIOCONJUGATE DRUG DELIVERY DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/383998
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383998 | APTAMER BIOCONJUGATE DRUG DELIVERY DEVICE | Apr 14, 2019 | Abandoned |
Array
(
[id] => 14926243
[patent_doc_number] => 20190298759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/384599
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384599 | Plant medium including an oxygen-enabled composition | Apr 14, 2019 | Issued |
Array
(
[id] => 16760948
[patent_doc_number] => 20210106529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => NANOLIPOSOME-MICROBUBBLE CONJUGATE INCLUDING DRUG FOR HAIR LOSS TREATMENT ENCAPSULATED IN NANOLIPOSOME AND COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 16/646887
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646887 | Nanoliposome-microbubble conjugate including drug for hair loss treatment encapsulated in nanoliposome and composition for alleviating or treating hair loss containing same | Apr 10, 2019 | Issued |
Array
(
[id] => 16718681
[patent_doc_number] => 20210085828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => IMPLANTABLE CELL DRESSING FOR TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/971430
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971430 | Implantable cell dressing for treatment of disease | Mar 21, 2019 | Issued |